Fresenius SE & Co. KGaA FRE.VI Stock
Fresenius SE & Co. KGaA Price Chart
Fresenius SE & Co. KGaA FRE.VI Financial and Trading Overview
| Fresenius SE & Co. KGaA stock price | 25.46 EUR |
| Previous Close | 25.46 EUR |
| Open | 25.45 EUR |
| Bid | 25.28 EUR x 0 |
| Ask | 25.52 EUR x 0 |
| Day's Range | 25.45 - 25.61 EUR |
| 52 Week Range | 20 - 29.47 EUR |
| Volume | 385 EUR |
| Avg. Volume | 159 EUR |
| Market Cap | 14.42B EUR |
| Beta (5Y Monthly) | 1.082375 |
| PE Ratio (TTM) | 11.038794 |
| EPS (TTM) | 0.63 EUR |
| Forward Dividend & Yield | 0.92 (3.60%) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | N/A |
FRE.VI Valuation Measures
| Enterprise Value | 51.48B EUR |
| Trailing P/E | 11.038794 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.34888136 |
| Price/Book (mrq) | 0.70252925 |
| Enterprise Value/Revenue | 1.245 |
| Enterprise Value/EBITDA | 10.379 |
Trading Information
Fresenius SE & Co. KGaA Stock Price History
| Beta (5Y Monthly) | 1.082375 |
| 52-Week Change | -13.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 29.47 EUR |
| 52 Week Low | 20 EUR |
| 50-Day Moving Average | 26.12 EUR |
| 200-Day Moving Average | 25.35 EUR |
FRE.VI Share Statistics
| Avg. Volume (3 month) | 159 EUR |
| Avg. Daily Volume (10-Days) | 21 EUR |
| Shares Outstanding | 563.24M |
| Float | 411.11M |
| Short Ratio | N/A |
| % Held by Insiders | 26.95% |
| % Held by Institutions | 37.07% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.92 |
| Trailing Annual Dividend Yield | 3.61% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.39830002 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 3.15% |
| Operating Margin (ttm) | 7.87% |
| Gross Margin | 26.02% |
| EBITDA Margin | 11.99% |
Management Effectiveness
| Return on Assets (ttm) | 2.71% |
| Return on Equity (ttm) | 6.31% |
Income Statement
| Revenue (ttm) | 41.34B EUR |
| Revenue Per Share (ttm) | 73.51 EUR |
| Quarterly Revenue Growth (yoy) | 5.20% |
| Gross Profit (ttm) | 10.73B EUR |
| EBITDA | 4.96B EUR |
| Net Income Avi to Common (ttm) | 1.3B EUR |
| Diluted EPS (ttm) | 2.32 |
| Quarterly Earnings Growth (yoy) | -16.19% |
Balance Sheet
| Total Cash (mrq) | 2.32B EUR |
| Total Cash Per Share (mrq) | 4.12 EUR |
| Total Debt (mrq) | 27.77B EUR |
| Total Debt/Equity (mrq) | 86.3 EUR |
| Current Ratio (mrq) | 1.2 |
| Book Value Per Share (mrq) | 36.454 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.27B EUR |
| Levered Free Cash Flow (ttm) | 2.39B EUR |
Profile of Fresenius SE & Co. KGaA
| Country | Austria |
| State | N/A |
| City | Bad Homburg vor der Höhe |
| Address | Else-Kroener-Strasse 1 |
| ZIP | 61352 |
| Phone | 49 6172 6080 |
| Website | https://www.fresenius.com |
| Industry | Medical Care Facilities |
| Sector(s) | Healthcare |
| Full Time Employees | 313812 |
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Q&A For Fresenius SE & Co. KGaA Stock
What is a current FRE.VI stock price?
Fresenius SE & Co. KGaA FRE.VI stock price today per share is 25.46 EUR.
How to purchase Fresenius SE & Co. KGaA stock?
You can buy FRE.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Fresenius SE & Co. KGaA?
The stock symbol or ticker of Fresenius SE & Co. KGaA is FRE.VI.
Which industry does the Fresenius SE & Co. KGaA company belong to?
The Fresenius SE & Co. KGaA industry is Medical Care Facilities.
How many shares does Fresenius SE & Co. KGaA have in circulation?
The max supply of Fresenius SE & Co. KGaA shares is 563.24M.
What is Fresenius SE & Co. KGaA Price to Earnings Ratio (PE Ratio)?
Fresenius SE & Co. KGaA PE Ratio is 40.41269700 now.
What was Fresenius SE & Co. KGaA earnings per share over the trailing 12 months (TTM)?
Fresenius SE & Co. KGaA EPS is 0.63 EUR over the trailing 12 months.
Which sector does the Fresenius SE & Co. KGaA company belong to?
The Fresenius SE & Co. KGaA sector is Healthcare.